Molecular mechanisms associated with angiotensin-converting enzyme-inhibitory peptide activity on vascular extracellular matrix remodeling

Cardiology (Switzerland)

Volumn 127, Issue 4, 2014, Pages 247-255

  Fang, Hong ^a   Chen, Wei ^a   Gao, Yang ^a   Shen, Yi ^a   Luo, Ming ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Collagen fibers; Hypertension; LAP; Primary hypertension; Vascular remodeling

Indexed keywords

ANGIOTENSIN II; COLLAGEN FIBER; DIPEPTIDYL CARBOXYPEPTIDASE; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LACTOFERRIN; LEUCYL-ARGINYL-PROLYL-VALYL-ALANYL-ALANINE; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; PEPTIDE FRAGMENT; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA1; NUCLEAR FACTOR; NUCLEAR FACTOR P65; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART RATE; INFLAMMATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; BLOOD PRESSURE; BLOOD VESSEL; DRUG EFFECTS; ELASTIC TISSUE; MALE; METABOLISM; RANDOMIZATION; RAT; COLLAGEN FIBER; DRUG MECHANISM; ELASTIC FIBER; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; VASCULAR EXTRACELLULAR MATRIX REMODELING; VASCULAR REMODELING;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CAROTID ARTERY, COMMON; COLLAGEN; ELASTIC TISSUE; EXTRACELLULAR MATRIX; HEART RATE; INFLAMMATION; LACTOFERRIN; LAMININ; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84893163870     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000356951     Document Type: Article

References (32)

1. van den Akker J, Tuna BG, Pistea A, Sleutel AJ, Bakker EN, van Bavel E: Vascular smooth muscle cells remodel collagen matrices by long-distance action and anisotropic interaction. Med Biol Eng Comput 2012; 50: 701-715.
2. Hong F, Min L, Yi S, Zhanxia L, Yongquan W, Chi L: The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 2008; 29: 1062-1071.
3. Pandey R, Quan WY, Hong F, Jie SL: Vaccine for hypertension: modulating the renin-an-giotensin system. Int J Cardiol 2009; 134: 16016-16018.
4. Rousseau-Ralliard D, Goirand F, Tardivel S, Lucas A, Algaron F, Mollé D, Robert V, Auchère D, Boudier JF, Gaillard JL, Monnet V, Tauzin J, Grynberg A: Inhibitory effect of aS1- and aS2-casein hydrolysates on angio-tensin I-converting enzyme in human endo-thelial cells in vitro, rat aortic tissue ex vivo, and renovascular hypertensive rats in vivo. J Dairy Sci 2010; 93: 2906-2921.
5. Ming L, Yi S, Chi L, Zheng H, Li Z, Deng Y, Huang J, Li L, Fang H: Long-term antihyper-tensive effect of angiotensin-converting enzyme inhibitory peptide LAP. Kidney Blood Press Res 2011; 34: 358-364.
6. Sutterer JR, Stoney CM, Sanfillipo M: Is the hypertensive rat really hyperreactive? Hypertension 1984; 6: 868-876.
7. Demidova-Rice TN, Geevarghese A, Herman IM: Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro. Wound Repair Regen 2011; 19: 59-70.
8. Intengan HD, Schiffrin EL: Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38: 581-587.
9. Phelan D, Watson C, Martos R, Collier P, Pa-tle A, Donnelly S, Ledwidge M, Baugh J, McDonald K: Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. PLoS One 2012; 7:e49259.
10. Renna NF, Lembo C, Diez E, Miatello RM: Role of renin-angiotensin system and oxidative stress on vascular inflammation in insulin resistance model. Int J Hypertens 2013; 2013:420979.
11. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC: p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 2004; 279:26115-26125.
12. Zhang L, Ma Y, Zhang J, Cheng J, Du J: A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-inde-pendent, RSK-mediated phosphorylation of p65. Arterioscler Thromb Vasc Biol 2005; 25: 1148-1153.
13. Sacharidou A, Stratman AN, Davis GE: Molecular mechanisms controlling vascular lumen formation in three-dimensional extracellular matrices. Cells Tissues Organs 2012; 195: 122-143.
14. Guyton JR, Lindsay KL, Dao DT: Comparison of aortic intima and inner media in young adult versus aging rats. Stereology in a polarized system. Am J Pathol 1983; 111: 234-246.
15. McGuire PG, Walker-Caprioglio HM, Little SA, McGuffee LJ: Isolation and culture of rat superior mesenteric artery smooth muscle cells. In Vitro Cell Dev Biol 1993; 29A:135-139.
16. McGuire PG, Brocks DG, Killen PD, Orkin RW: Increased deposition of basement membrane macromolecules in specific vessels of the spontaneously hypertensive rat. Am J Pathol 1989; 135: 291-299.
17. Lipke DW, McCarthy KJ, Elton TS, Arcot SS, Oparil S, Couchman JR: Coarctation induces alterations in basement membranes in the cardiovascular system. Hypertension 1993; 22: 743-753.
18. Lozito TP, Tuan RS: Endothelial cell mic-roparticles act as centers of matrix metallo-proteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol 2012; 227: 534-549.
19. Dodd T, Jadhav R, Wiggins L, Stewart J, Smith E, Russell JC, Rocic P: MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK. J Mol Cell Cardiol 2011; 51: 1015-1025.
20. Bolbrinker J, Markovic S, Wehland M, Me-lenhorst WB, van Goor H, Kreutz R: Expression and response to angiotensin-converting enzyme inhibition of matrix metalloprotein-ases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. J Pharmacol Exp Ther 2006; 316: 8-16.
21. Wang M, Zhang J, Spinetti G, Jiang LQ, Mon-ticone R, Zhao D, Cheng L, Krawczyk M, Ta-lan M, Pintus G, Lakatta EG: Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 2005; 167: 1429-1442.
22. Martinez-Lemus LA, Galiñanes EL: Matrix metalloproteinases and small artery remodel- ing. Drug Discov Today Dis Models 2011; 8: 21-28.
23. Ma KL, Liu J, Ni J, Zhang Y, Lv LL, Tang RN, Ni HF, Ruan XZ, Liu BC: Inflammatory stress exacerbates the progression of cardiac fibrosis in high-fat-fed apolipoprotein E knockout mice via endothelial-mesenchymal transition. Int J Med Sci 2013; 10: 420-426.
24. Silva PM: From endothelial dysfunction to vascular occlusion: role of the renin-angio-tensin system. Rev Port Cardiol 2010; 29:801-824.
25. Jesmin S, Sakuma I, Hattori Y, Kitabatake A: Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats. Arterioscler Thromb Vasc Biol 2003; 23: 2021-2026.
26. Chen JL, Shang QH, Hu W, Liu C, Mao WH, Liu HQ: Role of TGF-ß1/Smads pathway in carotid artery remodeling in renovascular hypertensive rats and prevention by enalapril and amlodipine. J Geriatr Cardiol 2012; 9: 185-191.
27. Dai J, Michineau S, Franck G, Desgranges P, Becquemin JP, Gervais M, Allaire E: Long term stabilization of expanding aortic aneu-rysms by a short course of cyclosporine A through transforming growth factor-beta induction. PLoS One 2011; 6:e28903.
28. Lemarié CA, Tharaux PL, Lehoux S: Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol 2010; 48: 433-439.
29. Lemarié CA, Simeone SM, Nikonova A, Ebra-himian T, Deschênes ME, Coffman TM, Par-adis P, Schiffrin EL: Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors. Circ Res 2009; 105: 852-859.
30. Lemarié CA, Tharaux PL, Esposito B, Tedgui A, Lehoux S: Transforming growth factor-alpha mediates nuclear factor kappaB activation in strained arteries. Circ Res 2006; 99: 434-441.
31. Viel EC, Lemarié CA, Benkirane K, Paradis P, Schiffrin EL: Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol 2010; 298:H938-H944.
32. Kim HJ, Kim MY, Jin H, Kim HJ, Kang SS, Kim HJ, Lee JH, Chang KC, Hwang JY, Yabe-Nishimura C, Kim JH, Seo HG: Peroxisome proliferator-activated receptor-d regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-ß 1/Smad3. Circ Res 2009; 105: 16-24.